E
GNMK

Ergoteles’s GenMark Diagnostics, Inc GNMK Stock Holding History

Ergoteles’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-149,543
Closed -$3.57M – 1788
2021
Q1 		$3.57M Buy
+149,543
New +$2.78M 0.11% 208

Ergoteles's GNMK Position: Q2 2021 in Review

Ergoteles sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 149,543 shares — an estimated $3.57M sold.

Ergoteles first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $3.57M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Ergoteles reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Ergoteles sold 149,543 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $3.57M.
  • Ergoteles first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • Ergoteles's GenMark Diagnostics, Inc position peaked at $3.57M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.